SYK Today - Aug 13: Downgrade Hits Stryker Hard

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

SYK Today - Aug 13: Downgrade Hits Stryker Hard

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey, your friendly neighborhood investor, here to break down what went down with Stryker today. So, Stryker (SYK) had a bit of a rough ride, closing down about 1.4%. Yeah, that one stung.

So, what happened? Well, the stock got smoked today, and it looks like the main culprit was a downgrade from Wolfe Research. They decided to lower their rating on Stryker, which made a lot of investors hit the sell button fast. It’s like when your favorite band gets a bad review; suddenly, you’re not feeling so good about the concert, right?

Now, why did Wolfe downgrade Stryker? They mentioned some shifts in the med-tech space, upgrading Abbott instead. Basically, they see better opportunities elsewhere, which isn’t great news for Stryker. It's a tough crowd out there, and Stryker's feeling the heat. Plus, Citigroup did adjust their price target for Stryker, bumping it up a bit to $399, but that didn’t help the stock today. When the mood’s down, it’s hard to shake it off, you know?

On the horizon, there's chatter about Stryker’s dividend stability and how that might reshape the investment case for them. That’s something to keep in mind as we see how things play out.

So, to wrap it up: Stryker had a red day thanks to a downgrade and some shifting sentiments in the med-tech world. Remember, this is just for information and entertainment — no buy or sell advice here. Catch you later, and happy investing!

まだレビューはありません